The Nottingham study of neurotic disorder: predictors of 12 year costs
Source: Acta Psychiatrica Scandinavica, Volume 112, Number 3, September 2005 , pp. 224-232(9)
Abstract:Knerer G, Byford S, Johnson T, Seivewright H, Tyrer P. The Nottingham study of neurotic disorder: predictors of 12 year costs.
Acta Psychiatr Scand 2005: 1–9. © 2005 Blackwell Munksgaard. Objective:
To examine the relationship between clinical, demographic and socio-economic characteristics and the long-term costs of a cohort of neurotic patients. Method:
Analysis of the costs of a cohort of 210 people entered in the Nottingham study of neurotic disorders, a randomized controlled evaluation of five treatments for neurotic disorders. Service use data were collected at 5 and 12 years after study entry. Multiple regression analyses were conducted. Results:
The total cost per patient over the 12-year follow-up period was calculated to be $11 940 (SD $15 520) (£7450, SD £9690). Higher costs were significantly associated with the presence of general neurotic syndrome, an initial diagnosis of dysthymia and a recurrent episode of illness. Conclusion:
The total costs of care for a range of neurotic disorders are broadly comparable with other estimates of costs reported in the literature for similar populations. Those responsible for higher costs in the longer-term have comorbid anxiety, depressive and personality disorders.
Document Type: Research Article
Affiliations: 1: Department of Mental Health Sciences, Royal Free and University College School of Medicine, London 2: Centre for the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London 3: Medical Research Council Biostatistics Unit, Robinson Way, Cambridge 4: Department of Psychological Medicine, Imperial College, London, UK
Publication date: September 1, 2005